Items where authors include "Willis, L.F."

Article

Willis, L.F., Brockwell, D.J. and Radford, S.E. orcid.org/0000-0002-3079-8039 (2025) In the Flow, How Fluid Dynamics Shapes Amyloid Formation. Proceedings of the National Academy of Sciences. ISSN 0027-8424 (In Press)

Taylor, A.I.P., Xu, Y., Wilkinson, M. et al. (7 more authors) (2025) Kinetic Steering of Amyloid Formation and Polymorphism by Canagliflozin, a Type-2 Diabetes Drug. Journal of the American Chemical Society. ISSN 0002-7863

Willis, L.F. orcid.org/0000-0001-6616-3716, Trayton, I., Saunders, J.C. et al. (11 more authors) (2025) Rationalising mAb candidate screening using a single holistic developability parameter. Molecular Pharmaceutics, 22 (1). pp. 181-195. ISSN 1543-8384

Willis, L.F. orcid.org/0000-0001-6616-3716, Kapur, N. orcid.org/0000-0003-1041-8390, Radford, S.E. orcid.org/0000-0002-3079-8039 et al. (1 more author) (2024) Biophysical Analysis of Therapeutic Antibodies in the Early Development Pipeline. Biologics: Targets and Therapy, 18. pp. 413-432. ISSN 1177-5475

Bryon, J., Wasson, C.W. orcid.org/0000-0001-6558-4738, Koeppen, K. et al. (7 more authors) (2024) Systemic Sclerosis dermal fibroblast exosomes trigger a Type 1 interferon response in keratinocytes through the TBK/JAK/STAT signalling axis. Arthritis & Rheumatology. ISSN 2326-5191

Willis, L.F. orcid.org/0000-0001-6616-3716, Toprani, V., Wijetunge, S. et al. (7 more authors) (2024) Exploring a Role for Flow-Induced Aggregation Assays in Platform Formulation Optimisation for Antibody-Based Proteins. Journal of Pharmaceutical Sciences, 113 (3). pp. 625-636. ISSN 0022-3549